Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4

Hessel H van der Zee; Johanna C van Huijstee; Kelsey R van Straalen; Gregor B E Jemec; Christos C Zouboulis; Thrasyvoulos Tzellos; Errol P Prens

doi:10.1159/000535867

Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4

Hessel H van der Zee^*, Johanna C van Huijstee, Kelsey R van Straalen, Gregor B E Jemec, Christos C Zouboulis, Thrasyvoulos Tzellos, Errol P Prens

^*Corresponding author af dette arbejde

Dermatologisk Afdeling

Publikation: Bidrag til tidsskrift › Letter › Forskning › peer review

Originalsprog	Engelsk
Sider (fra-til)	514-516
Antal sider	3
Tidsskrift	Dermatology
Vol/bind	240
Udgave nummer	3
DOI	https://doi.org/10.1159/000535867
Status	Udgivet - 2024

Adgang til dokumentet

10.1159/000535867

Citationsformater

@article{f19b9758b5744bed9adb9fc66f7992c9,

title = "Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa: The Cumulative IHS4",

keywords = "Hidradenitis Suppurativa/therapy, Humans, Severity of Illness Index, Treatment Outcome",

author = "\{van der Zee\}, \{Hessel H\} and \{van Huijstee\}, \{Johanna C\} and \{van Straalen\}, \{Kelsey R\} and Jemec, \{Gregor B E\} and Zouboulis, \{Christos C\} and Thrasyvoulos Tzellos and Prens, \{Errol P\}",

year = "2024",

doi = "10.1159/000535867",

language = "English",

volume = "240",

pages = "514--516",

journal = "Dermatology",

issn = "1018-8665",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Viewpoint on the Evaluation of Severity and Treatment Effects in Mild Hidradenitis Suppurativa

T2 - The Cumulative IHS4

AU - van der Zee, Hessel H

AU - van Huijstee, Johanna C

AU - van Straalen, Kelsey R

AU - Jemec, Gregor B E

AU - Zouboulis, Christos C

AU - Tzellos, Thrasyvoulos

AU - Prens, Errol P

PY - 2024

Y1 - 2024

KW - Hidradenitis Suppurativa/therapy

KW - Humans

KW - Severity of Illness Index

KW - Treatment Outcome

U2 - 10.1159/000535867

DO - 10.1159/000535867

M3 - Letter

C2 - 38118429

SN - 1018-8665

VL - 240

SP - 514

EP - 516

JO - Dermatology

JF - Dermatology

IS - 3

ER -